Characterization of a cancer cachectic factor (original) (raw)

Nature volume 379, pages 739–742 (1996)Cite this article

Abstract

CANCER cachexia is a syndrome of progressive wasting which has been suggested to be mediated by tumour-necrosis factor-α (ref. 1), interleukins 1 and 6 (ref. 2), interferon-γ (ref. 3) and leukaemia-inhibitory factor4. It has proved difficult to correlate levels of tumour-necrosis factor-α and interleukin-6 with cancer cachexia5,6, and the weight loss induced by leukaemia-inhibitory factor may be due to toxicity7. In the murine adenocarcinoma MAC 16, cachexia is mediated by circulatory catabolic factors8,9, which we have now isolated using an antibody cloned from splenocytes of mice transplanted with the MAC16 tumour, with a delayed cachexia10. The material is a proteoglycan of relative molecular mass 24K which produces cachexia in vivo by inducing catabolism of skeletal muscle. The 24K material was also present in urine of cachectic cancer patients, but was absent from normal subjects, patients with weight loss due to trauma, and cancer patients with little or no weight loss. This suggests that cachexia in mice and humans may be produced by the same material.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Beutler, B. & Cerami, A. Nature 320, 584–588 (1986).
    Article ADS CAS Google Scholar
  2. Strassman, G., Fong, M., Kenney, J. S. & Jacob, C. O. J. clin. Invest. 89, 1681–1684 (1992).
    Article Google Scholar
  3. Matthys, P. et al. Int. J. Cancer 49, 77–82 (1991).
    Article CAS Google Scholar
  4. Mori, M. et al. Cancer Res. 51, 6656–6659 (1991).
    CAS PubMed Google Scholar
  5. Socher, S. H., Martinez, D., Craig, J. B., Kuhn, J. K. & Oliff, A. J. natl. Cancer Inst. 80, 595–598 (1988).
    Article CAS Google Scholar
  6. Soda, K., Kawakami, M., Kashii, A. & Miyata, M. Jap. J. Cancer Res. 85, 1124–1130 (1994).
    Article CAS Google Scholar
  7. Metcalf, D., Nicola, N. A. & Gearing, D. P. Blood 76, 50–56 (1990).
    CAS Google Scholar
  8. Bibby, M. C. et al. J. natn. Cancer Inst. 78, 539–546 (1987).
    CAS Google Scholar
  9. Beck, S. A. & Tisdale, M. J. Cancer Res. 47, 5919–5923 (1987).
    CAS PubMed Google Scholar
  10. McDevitt, T. M., Todorov, P. T., Beck, S. A., Khan, S. H. & Tisdale, M. J. Cancer Res. 55, 1458–1463 (1995).
    CAS PubMed Google Scholar
  11. Yoshizawa, N., Oshima, S., Sagel, I., Shimizu, J. & Treser, G. J. Immun. 148, 3110–3116 (1992).
    CAS PubMed Google Scholar
  12. Plumb, J. A., Fearon, K. C. H., Carter, K. B. & Preston, T. Clin. Nutr. 10, 23–29 (1991).
    Article CAS Google Scholar
  13. Smith, K. L. & Tisdale, M. J. Br. J. Cancer 68, 314–318 (1993).
    Article CAS Google Scholar
  14. McDevitt, T. M. & Tisdale, M. J. Br. J. Cancer 66, 815–820 (1992).
    Article CAS Google Scholar
  15. Goldberg, A., Kettlehut, K., Fagan, J. & Baracos, V. J. clin. Invest. 81, 1378–1383 (1988).
    Article CAS Google Scholar
  16. Garcia-Martinez, C., Lopez-Soriano, F. J. & Argiles, J. M. Cancer Lett. 76, 1–4 (1994).
    Article CAS Google Scholar
  17. Beck, S. A., Smith, K. L. & Tisdale, M. J. Cancer Res. 51, 6089–6093 (1991).
    CAS PubMed Google Scholar

Download references

Author information

Author notes

  1. Brian Coles: CRC Molecular Toxicology Group, Department of Biochemistry, University College and Middlesex School of Medicine, Windeyer Building, Cleveland Street, London W1P 6D8, UK
  2. Kenneth Fearon: Department of Surgery, University of Edinburgh, Royal Infirmary, Lauriston Place, Edinburgh EH3 9YW, UK
  3. Michael Tisdale: To whom correspondence should be addressed.

Authors and Affiliations

  1. CRC Nutritional Biochemistry Research Group, Pharmaceutical Sciences Institute, Aston University, Birmingham, B4 7ET, UK
    Penio Todorov, Peter Cariuk, Trudi McDevitt, Brian Coles, Kenneth Fearon & Michael Tisdale

Authors

  1. Penio Todorov
    You can also search for this author inPubMed Google Scholar
  2. Peter Cariuk
    You can also search for this author inPubMed Google Scholar
  3. Trudi McDevitt
    You can also search for this author inPubMed Google Scholar
  4. Brian Coles
    You can also search for this author inPubMed Google Scholar
  5. Kenneth Fearon
    You can also search for this author inPubMed Google Scholar
  6. Michael Tisdale
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Todorov, P., Cariuk, P., McDevitt, T. et al. Characterization of a cancer cachectic factor.Nature 379, 739–742 (1996). https://doi.org/10.1038/379739a0

Download citation

This article is cited by